Current Press Release

Munich Leukemia Laboratory Developing a Digital Order Entry Platform

In this digital age, MLL has now set up a way to enter orders online. Following an extensive beta testing phase in the outpatient area, it is now possible to use a corresponding digital platform free of charge.

There are many advantages to digital order entry. It is no longer necessary to print out and send paper documents – all patient information can be conveyed digitally. An assistance system helps with the order process, such as by checking the information provided for plausibility or by giving entity-specific diagnostic recommendations according to applicable guidelines. Accompanying material such as findings or doctor’s letters can be uploaded together with the order, and any laboratory values are automatically retrieved from the doctor information system (DIS).

Read more

Press archives

E-Mail Newsletter (MLL News)

Our newsletter is an offer of MLL Münchner Leukämielabor GmbH, Max-Lebsche-Platz 31, 81377 Munich (“MLL,” “we”) and contains information about our products and services, research results, events and other news relevant to the company and to the discipline, especially regarding diagnostics and subsequent therapy for leukemia and lymphoma. For you to subscribe, we need the e-mail address that you want us to send the newsletter to. We may use optional information to personalize how the addressee is addressed.
To continuously improve the quality of our newsletter and its contents, we conduct a pseudonymized analysis of the opening rate of the newsletter and information on calling up specific articles. You can find detailed information on how personal data is processed in connection with our newsletter in our Data protection information section.


By clicking on the “Subscribe to the newsletter” button, I consent to allow MLL to use the e-mail address and optional information provided by me for sending the newsletter and for addressing me personally.

 

Newsletter registration

You have the right to withdraw your consent at any time. Withdrawing your consent does not affect the lawfulness of the processing that took place based on your consent up until the time of withdrawal. One way you can withdraw your consent is by using the withdrawal function contained in every newsletter. Alternatively, you can declare that you are withdrawing your consent by sending an e-mail to or by mailing a letter to MLL Münchner Leukämielabor GmbH, Max-Lebsche-Platz 31, 81377 Munich.

MLL Magazine

Stay up to date

Here you will find all MLL News as well as scientific contributions to leukemia diagnostics and research.

to the MLL Magazine

Current Articles

  • Dr. rer. nat. Ines Schmidts
    from 18.02.2020
    Automation & Artificial Intelligence
    The Use of Artificial Intelligence at MLL Munich Leukemia Laboratory

    Whether a search engine or digital assistant is involved, artificial intelligence (AI) has long been a part of our day-to-day work. There are success stories in imaging-based diagnostics thanks to AI as well. Preliminary studies, for example, indicate that the classification of medical findings using AI is equivalent to traditional methods.

    Post review
    • Current rating is 5.0 out of 5
    • 1
    • 2
    • 3
    • 4
    • 5
    Read article
  • Dr. rer. nat. Constance Bär
    from 18.02.2020
    Diagnostics
    Assessing Sequence Variants

    Sequencing technologies have developed rapidly in the last few years. It is possible to sequence an entire genome or a larger panel within just a few days. At the MLL, data from the sequencing machine is loaded to our private cloud in real time and automatically preprocessed using the very latest algorithms.

    Post review
    • Current rating is 5.0 out of 5
    • 1
    • 2
    • 3
    • 4
    • 5
    Read article

Events

Contact

Sarah Kurz

MLL Münchner Leukämielabor GmbH
Max-Lebsche-Platz 31
81377 München

T: +49 (0)89 99017-547

Getting here
We want to provide the most important information and services for you in the best-possible way.

To do this, we need your consent to use the ‘Matomo’ web analysis tool to create and carry out an pseudonymous evaluation of your visit for statistical purposes. Your consent is valid for 12 months.

You can find all the information about cookies, their management and your cancellation rights in our Privacy Policy.

accept
decline